Latest News Archive
Please select Category, Year, and then Month to display items
12 October 2020
|
Story Arina Engelbrecht
|
Photo Supplied
Arina Engelbrecht from Organisational Development and Employee Well-being believes physical activity has a number of benefits for one’s health, including stress relief.
Being physically active plays a big role in preventing the development of mental-health problems and in improving the quality of life of people experiencing mental-health problems.
Treatment for depression
Physical activity can be an alternative treatment for depression. It can be used as a stand-alone treatment or in combination with medication and/or psychological therapy. It promotes all kinds of changes in the brain, including neural growth, reduced inflammation, and new activity patterns are formed that promote feelings of calm and well-being. It releases endorphins – powerful chemicals in the brain that energise your spirit and make you feel good.
Physical activity can be very effective in relieving stress. Research in adults has found that physically active individuals tend to have lower stress levels compared to individuals who are less active. It also leads to improved sleep. When a person sleeps better and feels more rested, overall quality of life improves. They cope better with daily life stressors.
Reduce Alzheimer's risk
Regular physical activity can reduce your risk of developing Alzheimer's disease by up to 50%. It can also slow down further deterioration in those who have already started to develop cognitive problems. It stimulates the brain’s ability to maintain old connections as well as to make new ones.
A study asked people to rate their mood immediately after periods of physical activity (e.g. going for a walk/run, cycling, doing housework) and periods of inactivity (e.g. reading a book or watching television). Researchers found that participants felt more content, more awake, and calmer after being physically active compared to after periods of inactivity.
In conclusion, people who are physically active feel a sense of well-being, feel more energetic throughout the day, sleep better at night, have sharper memories, and feel more relaxed and positive about themselves and their lives.
“Being physically active not only changes your body, it changes your mind,
attitude, and your mood.” – Arina Engelbrecht
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004